Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

Looking for an online ALS group? Columnist Dagmar Munn has you covered with helpful tips gleaned from years as a forums co-moderator.

Neuropeutics is collaborating with LifeArc on a small molecule therapy that reportedly lowered TDP-43 clumping in an animal ...

In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.